177 related articles for article (PubMed ID: 2869590)
1. The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study.
Offermeier J; van Rooyen JM; Rossouw J
S Afr Med J; 1986 Feb; 69(4):234-6. PubMed ID: 2869590
[TBL] [Abstract][Full Text] [Related]
2. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
[TBL] [Abstract][Full Text] [Related]
3. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
4. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
Moreira TS; Takakura AC; Menani JV; Colombari E
Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects and interaction with adrenoceptors of urapidil.
van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
[TBL] [Abstract][Full Text] [Related]
9. [Importance of radioreceptor assays in determining the mechanism of action of hypotensive alpha-adrenergic compounds].
Dausse JP; Guicheney P; Meyer P
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():45-50. PubMed ID: 6271088
[TBL] [Abstract][Full Text] [Related]
10. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
Tsuchihashi H; Nagatomo T
J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
[TBL] [Abstract][Full Text] [Related]
11. Subtype-selective alpha-1 adrenoceptor alkylation in the rat kidney and its effect on the vascular pressor response.
Elhawary AM; Pettinger WA; Wolff DW
J Pharmacol Exp Ther; 1992 Feb; 260(2):709-13. PubMed ID: 1346641
[TBL] [Abstract][Full Text] [Related]
12. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
Honda K; Takenaka T; Miyata-Osawa A; Terai M
J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
[TBL] [Abstract][Full Text] [Related]
13. Contribution of alpha 2-adrenoceptors to the central cardiovascular effects of clonidine and S 8350 in anaesthetized rats.
Deckert V; Lachaud V; Parini A; Elghozi JL
Clin Exp Pharmacol Physiol; 1991 Oct; 18(10):401-8. PubMed ID: 1684919
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive synergism of MD-354 and clonidine. Part II. The alpha-adrenoceptor component.
Young S; Vainio M; Scheinin M; Dukat M
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):690-7. PubMed ID: 20353485
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
Langer SZ; Duval N; Massingham R
J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
[TBL] [Abstract][Full Text] [Related]
16. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
[TBL] [Abstract][Full Text] [Related]
17. Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.
Van Zwieten PA; Timmermans PB; Van Brummelen P
Am J Med; 1984 Oct; 77(4A):17-25. PubMed ID: 6148891
[TBL] [Abstract][Full Text] [Related]
18. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA
J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
Hamilton CA; Reid JL; Vincent J
Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of α2 -adrenoceptors in modulating myogenic tone in sheep isolated internal anal sphincter.
Rayment SJ; Simpson JA; Eames T; Acheson AG; Dashwood MR; Henry Y; Gruss H; Scholefield JH; Wilson VG
Neurogastroenterol Motil; 2014 Aug; 26(8):1095-103. PubMed ID: 24906134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
